Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Lung Neoplasms 2Head and Neck Neoplasms 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Stomach Neoplasms 1Skin Neoplasms 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Melanoma 1Lymphoma 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Myeloid, Acute 1Immunoglobulin Light-chain Amyloidosis 1Hodgkin Disease 1Epstein-Barr Virus Infections 1Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Amyloidosis 1

Interventions

Trastuzumab 625Paclitaxel 576Cyclophosphamide 555Docetaxel 484Capecitabine 401Letrozole 376Fulvestrant 326Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 184Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 138Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × In Situ Hybridization × Clear all
NCT05754047 2023-03-03

Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients

Shahid Beheshti University of Medical Sciences

Completed
3,582 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡